Correction To: Castration-Resistant Prostate Cancer Patients Who Had Poor Response on First Androgen Deprivation Therapy Would Obtain Certain Clinical Benefit From Early Docetaxel Administration

International Journal of Clinical Oncology - Japan
doi 10.1007/s10147-019-01395-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation

Asian Journal of Andrology
MedicineUrology
2013English

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Methylation of SRD5A2 Promoter Predicts a Better Outcome for Castration-Resistant Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

PLoS ONE
Multidisciplinary
2020English

The Effects of Matrine in Combination With Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer

Cancer Management and Research
Oncology
2019English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2014English

Impact of Long-Term Androgen Deprivation Therapy on PSMA Ligand PET/CT in Patients With Castration-Sensitive Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy